AKERO THERAPEUTICS IN
48.97
22-5月-25 13:45:00
15 分の遅延
株式
+0.62
+1.28%
本日の幅
47.99 - 50.54
ISIN
N/A
ソース
NASDAQ
-
Akero Therapeutics to Present at the H.C. Wainwright 8th Annual MASH Virtual Conference
30 9 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
09 9 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
28 8 2024 13:05:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
09 8 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
11 6 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
08 6 2024 05:15:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the Jefferies Global Healthcare Conference
29 5 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
10 5 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
08 5 2024 04:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
30 4 2024 05:00:01 提供 Nasdaq GlobeNewswire
-
08 3 2024 13:02:00 提供 Nasdaq GlobeNewswire
-
07 3 2024 13:01:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
05 3 2024 18:13:56 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Proposed Public Offering of Common Stock
04 3 2024 13:21:12 提供 Nasdaq GlobeNewswire
-
04 3 2024 03:00:00 提供 Nasdaq GlobeNewswire
-
29 2 2024 05:00:00 提供 Nasdaq GlobeNewswire
-
29 2 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 1 2024 05:15:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces First Patients Dosed in Efruxifermin Phase 3 SYNCHRONY Program
18 12 2023 04:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
13 11 2023 04:00:00 提供 Nasdaq GlobeNewswire